Passive reporting greatly underestimates the rate of transfusion-associated circulatory overload after platelet transfusion

Vox Sanguinis

Volumn 108, Issue 4, 2015, Pages 387-392

  Raval, J S ^a   Mazepa, M A ^a   Russell, S L ^b   Immel, C C ^b   Whinna, H C ^a   Park, Y A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

Platelet; Transfusion; Transfusion associated circulatory overload; Volume overload

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION REACTION; DYSPNEA; FEMALE; HUMAN; HYPERTENSION; HYPOXIA; LUNG AUSCULTATION; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; RETROSPECTIVE STUDY; THROMBOCYTE TRANSFUSION; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; MEDICAL RECORD; PULMONARY EDEMA; RISK FACTOR; STANDARDS; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MEDICAL RECORDS; PLATELET TRANSFUSION; PROSPECTIVE STUDIES; PULMONARY EDEMA; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84927911718     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12234     Document Type: Article

References (22)

1. Mazzei CA, Popovsky MA, Kopko PM: Noninfectious complications of blood transfusion; in: Roback JD, Grossman BJ, Harris T, et al. (eds): Technical Manual. Bethesda, MD, AABB Press, 2011:727-762
2. Raval JS, Yazer MH: Nonallergic reactions to platelets; in: Sweeney J, Lozano M (eds): Platelet Transfusion Therapy. Bethesda, MD, AABB Press, 2013:516-519
3. Popovsky MA, Audet AM, Andrzejewski C Jr: Transfusion-associated circulatory overload in orthopedic surgery patients: a multi-institutional study. Immunohematology 1996; 12:87-89
4. Zhou L, Giacherio D, Cooling L, et al.: Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload. Transfusion 2005; 45:1056-1063
5. Li G, Rachmale S, Kojicic M, et al.: Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion 2011; 51:338-343
6. Murphy EL, Kwaan N, Looney MR, et al.: Risk factors and outcomes in transfusion-associated circulatory overload. Am J Med 2013; 126:357.e29-357.e38
7. Menis M, Anderson SA, Forshee RA, et al.: Transfusion-associated circulatory overload (TACO) and potential risk factors among the inpatient US elderly as recorded in Medicare administrative databases during 2011. Vox Sang 2014; 106:144-152
8. ISBT Working Party on Haemovigilance: Proposed Standard Definitions for Surveillance of Non Infectious Adverse Transfusion Reactions. ISBT and the International Haemovigilance Network, Amsterdam, the Netherlands 2011
9. Tobian AA, Sokoll LJ, Tisch DJ, et al.: N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Transfusion 2008; 48:1143-1150
10. U.S. Food and Drug Administration: Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2013. 2013. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm346639.htm [Last accessed 1 May 2014]
11. Bierbaum BE, Callaghan JJ, Galante JO, et al.: An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81:2-10
12. Rana R, Fernandez-Perez ER, Khan SA, et al.: Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 2006; 46:1478-1483
13. Narick C, Triulzi DJ, Yazer MH: Transfusion-associated circulatory overload after plasma transfusion. Transfusion 2012; 52:160-165
14. Whitaker BI, Hinkins S: The 2011 National Blood Collection and Utilization Survey Report. U.S. Department of Health and Human Services, Washington, D.C. 2011
15. Liumbruno G, Bennardello F, Lattanzio A, et al.: Recommendations for the transfusion of plasma and platelets. Blood Transfus 2009; 7:132-150
16. Sesok-Pizzini D, Herman JH: Platelet transfusion therapy; in: Mintz PD (ed.): Transfusion Therapy: Clinical Principles and Practice. Bethesda, MD, AABB Press, 2011:397-432
17. Blumberg N, Heal JM, Gettings KF, et al.: An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 2010; 50:2738-2744
18. Andrzejewski C Jr, Casey MA, Popovsky MA: How we view and approach transfusion-associated circulatory overload: pathogenesis, diagnosis, management, mitigation, and prevention. Transfusion 2013; 53:3037-3047
19. Kanai R, Iijima T, Hashimoto S, et al.: Impact of immunoreactive substances contained in apheresis platelet concentrate on postoperative respiratory function in surgical patients receiving platelet transfusion: a prospective cohort study. Transfus Med 2013; 23:344-350
20. Sink BLS: Administration of blood components; in Roback JD, Grossman BJ, Harris T, et al. (eds): Technical Manual. Bethesda, MD, AABB Press, 2011:625
21. Becker JL: Administration of blood components; in: Mintz PD (ed.): Transfusion Therapy: Clinical Principles and Practices. Bethesda, MD, AABB Press, 2011:789
22. Alam A, Lin Y, Lima A, et al.: The prevention of transfusion-associated circulatory overload. Transfus Med Rev 2013; 27:105-112